Skip Navigation
Find a Doctor
 
 
 
 

 

Photo of Dr. Ashley Evan Ross, M.D., Ph.D.

Ashley Evan Ross, M.D., Ph.D.

Assistant Professor of Urology

Male

Appointment Phone

410-955-6108

Main Location

The Johns Hopkins Hospital

Out-of-State & International Patients +
Out of State Patients

Call 410-464-6641 (8a.m. to 6p.m., EST, Mon-Fri)

Learn more about our out-of-state patient services »

International Patients

Call +1-410-502-7683 (7a.m. to 6p.m., EST, Mon-Fri)

Learn more about our international patient services »

Titles

  • Assistant Professor of Urology
  • Assistant Professor of Oncology
  • Assistant Professor of Pathology

Centers & Institutes

Departments

Locations

The Johns Hopkins Hospital

Appointment Phone: 410-955-6108

600 N. Wolfe Street
Sheikh Zayed Tower
Baltimore, MD 21287 map
Phone: 410-955-4494

Johns Hopkins Outpatient Center

601 N. Caroline Street
Baltimore, MD 21287 map
Phone: 410-955-4494

Expertise

Urology

Research Interests

Active surveillance of prostate cancer; Prostate cryotherapy; Prostate carcinogenesis; Prostate cancer

Biography

Dr. Ashley Evan Ross is an assistant professor of urology, oncology and pathology at the Johns Hopkins School of Medicine. His clinical practice focuses on prostate cancer and prostatic diseases.

He has expertise in open and robotic treatment of prostate cancer as well as in focal and salvage prostate cryotherapy and in the active surveillance of prostate cancer. Additionally, Dr. Ross has experience in the treatment of benign prostatic hyperplasia through the use of transurethral resection, laser photo-vaporization and open surgical approaches. As an active member of the Sidney Kimmel Comprehensive Cancer Center, Dr. Ross offers multidisciplinary approaches to the treatment of prostate cancer.

Dr. Ross received his undergraduate degree in biochemistry from the University of Maryland. He earned his graduate and medical degrees from the Johns Hopkins School of Medicine. Dr. Ross joined the faculty in 2012 after completing his general surgery and urology residency and fellowship at Johns Hopkins.

Dr. Ross’s research focuses on prostate carcinogenesis. His laboratory investigates molecular mechanisms that drive prostate cancer and is developing and testing novel targeted therapies for this aggressive disease. Dr. Ross is known for his discovery of how to use Relaxin 1 (RLXN1) as a tissue/urine/blood-based biomarker of high-grade prostate cancer.

Dr. Ross has been recognized with numerous awards and honors. He served as the chief resident in the Department of Urology’s residency program at Johns Hopkins. Most recently, he was recognized with a first prize for a paper presentation at the Baltimore-Washington-West Virginia Urology Resident Day. He is a member of the American Urologic Association.

...read more

    Additional Information

  • Education +

    Degrees

    • Johns Hopkins University School of Medicine / MD PhD (2006)

    Residencies

    • Johns Hopkins University School of Medicine / Urology (2012)

    Certifications

    • American Board of Urology / Urology (2014)
  • Research & Publications +

    Research Summary

    Dr. Ross is a fully trained scientist and an expert on prostate carcinogenesis. His research examines the molecular mechanisms that drive prostate cancer, and he develops and tests targeted therapies for treating prostate cancer. Dr. Ross patented his discovery of how to use Relaxin 1 (RLXN1) as a tissue/urine/blood-based biomarker of high-grade prostate cancer.

    Dr. Ross’ research focuses on diagnosing high-risk prostate cancer patients. Recent studies used a newly developed clinical test based on the specific pattern of gene expression from the primary tumor to help predict which men with an elevated PSA after radical prostatectomy will go on to develop metastatic disease.

    He and his colleagues also analyzed data regarding high-risk prostate cancer patients and identified a new subgroup of men with localized prostate cancer: men at very high risk of having metastasis and death from prostate cancer after prostatectomy.

    By better identifying patients who are high risk for metastatic cancer, doctors can offer more effective, targeted prostate cancer treatment.

    Lab:

    Dr. Ross’ laboratory investigates the molecular mechanisms that drive prostate cancer. He is developing and testing novel targeted therapies for this aggressive disease. Additionally, researchers in his lab are developing tests to guide the best diagnostic and treatment selection for each individual prostate cancer patient.

    Selected Publications View all on PubMed

    1. Sundi D, Wang VM, Pierorazio PM, Han M, Bivalacqua TJ, Ball MW, Antonarakis ES, Partin AW, Schaeffer EM, Ross AE. "Very-high-risk localized prostate cancer: definition and outcomes." Prostate Cancer and Prostatic Disease. 2013 Nov 5. doi: 10.1038/pcan.2013.46. [Epub ahead of print].
    2. Ross AE, Feng FY, Ghadessi M, Erho N, Crisan A, Buerki C, Sundi D, Mitra AP, Vergara IA, Thompson DJ, Triche TJ, Davicioni E, Bergstralh EJ, Jenkins RB, Karnes RJ, Schaeffer EM. "A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy." Prostate Cancer and Prostatic Disease. 2013 Oct 22. doi: 10.1038/pcan.2013.49. [Epub ahead of print].
    3. Ciolino JB, Stefanescu CF, Ross AE, Salvador-Culla B, Cortez P, Ford EM, Wymbs KA, Sprague SL, Mascoop DR, Rudina SS, Trauger SA, Cade F, Kohane DS. "In vivo performance of a drug-eluting contact lens to treat glaucoma for a month." Biomaterials. 2014 Jan;35(1):432-9. doi: 10.1016/j.biomaterials.2013.09.032. Epub 2013 Oct 4.
    4. Pierorazio PM, Gorin MA, Ross AE, Feng Z, Trock BJ, Schaeffer EM, Han M, Epstein JI, Partin AW, Walsh PC, Bivalacqua TJ. "Pathological and oncologic outcomes for men with positive lymph nodes at radical prostatectomy: The Johns Hopkins Hospital 30-year experience." Prostate. 2013 Nov;73(15):1673-80. doi: 10.1002/pros.22702. Epub 2013 Sep 9.
    5. Fang H, Pajski ML, Ross AE, Venton BJ. "Quantitation of dopamine, serotonin and adenosine content in a tissue punch from a brain slice using capillary electrophoresis with fast-scan cyclic voltammetry detection." Analytical methods: advancing methods and applications. 2013;5(11):2704-2711.
  • Academic Affiliations & Courses +
  • Activities & Honors +

    Honors

    • Junior Merck Index Award, 1996
    • Undergraduate Research Fellowship, Howard Hughes Medical Institute , 1996
    • University of Maryland Senior Summer Scholarship, University of Maryland , 1996
    • Medical Scientist Training Program Fellowship, 1997
    • Pathology Young Investigator’s Award for Excellence in Clinical Research, 2005
    • Academy of Achievement Award, 2006
    • Surgical Intern of the Year, Johns Hopkins Hospital, 2006
    • Shining Star Award, Johns Hopkins Bayview Medical Center , 2007
    • Surgery Clerkship Teaching Award, Johns Hopkins Hospital, 2007
    • Catch A Shining Star Annual Award Winner, Johns Hopkins Hospital, 2008
    • Shining Star Award, Johns Hopkins Bayview Medical Center , 2008
    • Osler Medical Housestaff Teaching Award, Johns Hopkins Department of Medicine , 2009
    • Chief Resident, Johns Hopkins Medical Institution, 2010 - 2012
    • Honorable Mention, Johns Hopkins University Fifth Annual Prostate Research Day, 2010
    • First Prize, Paper Presentation, Baltimore-Washington-West Virginia Urology Resident Day, 2012
    • Honorable Mention, Johns Hopkins University Seventh Annual Prostate Research Day, 2012

    Memberships

    • Alpha Omega Alpha (AOA), 2006
    • American Urologic Association, 2008
  • Videos & Media +
Is This You? Edit Profile
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.